Onartuzumab Chemische Eigenschaften,Einsatz,Produktion Methoden
Beschreibung
Onartuzumab is a monoclonal antibody that blocks the binding of HGF to the MET receptor.
Clinical Use
Onartuzumab is ineffective in improving clinical outcomes in (i) combination with current first-line chemotherapy in advanced nonsquamous cell NSCLC , (ii) combination with erlotinib in previously treated stage IIIB or IV NSCLC patients (Phase III) , and (iii) combination with platinum-doublet chemotherapy in advanced squamous cell NSCLC (Phase II) .
Onartuzumab Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
